BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 16920718)

  • 1. Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair.
    Bentle MS; Reinicke KE; Bey EA; Spitz DR; Boothman DA
    J Biol Chem; 2006 Nov; 281(44):33684-96. PubMed ID: 16920718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation.
    Dong Y; Bey EA; Li LS; Kabbani W; Yan J; Xie XJ; Hsieh JT; Gao J; Boothman DA
    Cancer Res; 2010 Oct; 70(20):8088-96. PubMed ID: 20940411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis.
    Huang X; Dong Y; Bey EA; Kilgore JA; Bair JS; Li LS; Patel M; Parkinson EI; Wang Y; Williams NS; Gao J; Hergenrother PJ; Boothman DA
    Cancer Res; 2012 Jun; 72(12):3038-47. PubMed ID: 22532167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ex vivo supplementation with nicotinic acid enhances cellular poly(ADP-ribosyl)ation and improves cell viability in human peripheral blood mononuclear cells.
    Weidele K; Kunzmann A; Schmitz M; Beneke S; Bürkle A
    Biochem Pharmacol; 2010 Oct; 80(7):1103-12. PubMed ID: 20599792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PARP-1 hyperactivation and reciprocal elevations in intracellular Ca2+ during ROS-induced nonapoptotic cell death.
    Zhang F; Xie R; Munoz FM; Lau SS; Monks TJ
    Toxicol Sci; 2014 Jul; 140(1):118-34. PubMed ID: 24752504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction.
    Cipriani G; Rapizzi E; Vannacci A; Rizzuto R; Moroni F; Chiarugi A
    J Biol Chem; 2005 Apr; 280(17):17227-34. PubMed ID: 15750180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytic poly(ADP-ribose) polymerase-1 activation leads to bioenergetic depletion and inhibition of glutamate uptake capacity.
    Tang KS; Suh SW; Alano CC; Shao Z; Hunt WT; Swanson RA; Anderson CM
    Glia; 2010 Mar; 58(4):446-57. PubMed ID: 19795500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone.
    Bey EA; Bentle MS; Reinicke KE; Dong Y; Yang CR; Girard L; Minna JD; Bornmann WG; Gao J; Boothman DA
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11832-7. PubMed ID: 17609380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose deprivation converts poly(ADP-ribose) polymerase-1 hyperactivation into a transient energy-producing process.
    Buonvicino D; Formentini L; Cipriani G; Chiarugi A
    J Biol Chem; 2013 Dec; 288(51):36530-7. PubMed ID: 24194524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of oxidant-induced cell death in Caco-2 colon carcinoma cells after inhibition of poly(ADP-ribose) polymerase and Ca2+ chelation: involvement of a common mechanism.
    Karczewski JM; Peters JG; Noordhoek J
    Biochem Pharmacol; 1999 Jan; 57(1):19-26. PubMed ID: 9920281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalase abrogates β-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers.
    Bey EA; Reinicke KE; Srougi MC; Varnes M; Anderson VE; Pink JJ; Li LS; Patel M; Cao L; Moore Z; Rommel A; Boatman M; Lewis C; Euhus DM; Bornmann WG; Buchsbaum DJ; Spitz DR; Gao J; Boothman DA
    Mol Cancer Ther; 2013 Oct; 12(10):2110-20. PubMed ID: 23883585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W; Alano CC; Garnier P; Swanson RA
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone.
    Bentle MS; Reinicke KE; Dong Y; Bey EA; Boothman DA
    Cancer Res; 2007 Jul; 67(14):6936-45. PubMed ID: 17638905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
    Lin CH; Lin PH
    Chem Biol Interact; 2006 Aug; 162(2):181-94. PubMed ID: 16884709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage.
    Rancourt A; Satoh MS
    DNA Repair (Amst); 2009 Mar; 8(3):286-97. PubMed ID: 19144573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
    Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
    BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells.
    Park EJ; Min KJ; Lee TJ; Yoo YH; Kim YS; Kwon TK
    Cell Death Dis; 2014 May; 5(5):e1230. PubMed ID: 24832602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP-1 inhibition prevents oxidative and nitrosative stress-induced endothelial cell death via transactivation of the VEGF receptor 2.
    Mathews MT; Berk BC
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):711-7. PubMed ID: 18239155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vincristine attenuates N-methyl-N'-nitro-N-nitrosoguanidine-induced poly-(ADP) ribose polymerase activity in cardiomyocytes.
    Zhang J; Chatterjee K; Alano CC; Kalinowski MA; Honbo N; Karliner JS
    J Cardiovasc Pharmacol; 2010 Mar; 55(3):219-26. PubMed ID: 20375713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.